NON-COMPETITION, NON-DISCLOSURE AND INTELLECTUAL PROPERTY ASSIGNMENT AGREEMENTNon-Competition, Non-Disclosure and Intellectual Property Assignment Agreement • May 18th, 2007 • Biosite Inc • In vitro & in vivo diagnostic substances • California
This Non-competition, Non-disclosure and Intellectual Property Assignment Agreement (the “Agreement”) entered into as of May 17, 2007, is hereby made by and between INVERNESS MEDICAL INNOVATIONS, INC., a Delaware corporation (the “Company”) and, BIOSITE INCORPORATED, a Delaware corporation (the “Employer”), on the one hand, and Gunars Valkirs, an individual, who is a resident of and employed in the State of California (“Employee”), on the other hand.
AGREEMENT AND PLAN OF MERGER by and among: INVERNESS MEDICAL INNOVATIONS, INC., a Delaware corporation; INCA ACQUISITION, INC., a Delaware corporation; and BIOSITE INCORPORATED, a Delaware corporation Dated as of May 17, 2007Merger Agreement • May 18th, 2007 • Biosite Inc • In vitro & in vivo diagnostic substances • Delaware
THIS AGREEMENT AND PLAN OF MERGER (“Agreement”) is made and entered into as of May 17, 2007, by and among INVERNESS MEDICAL INNOVATIONS, INC., a Delaware corporation (“Parent”); INCA ACQUISITION, INC., a Delaware corporation and a wholly-owned Subsidiary of Parent (“Purchaser”); and BIOSITE INCORPORATED, a Delaware corporation (the “Company”). Certain capitalized terms used in this Agreement are defined in Exhibit A.
AMENDMENT NO. 4 TO RIGHTS AGREEMENTRights Agreement • May 18th, 2007 • Biosite Inc • In vitro & in vivo diagnostic substances • Delaware
THIS AMENDMENT NO. 4 TO RIGHTS AGREEMENT (the “Amendment”) is made as of the 17 day of May, 2007, by and between BIOSITE INCORPORATED, a Delaware corporation (the “Company”), and AMERICAN STOCK TRANSFER & TRUST COMPANY, a New York banking corporation (the “Rights Agent”).
